• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非裔美国人健康项目中一种简短便携式肌肉减少症测量方法的开发与验证

Development and validation of a short portable sarcopenia measure in the African American health project.

作者信息

Miller Douglas K, Malmstrom Theodore K, Andresen Elena M, Miller J Philip, Herning Margaret M, Schootman Mario, Wolinsky Fredric D

机构信息

Center for Aging Research, Indiana University, Indianapolis, IN 46202, USA.

出版信息

J Gerontol A Biol Sci Med Sci. 2009 Mar;64(3):388-94. doi: 10.1093/gerona/gln033. Epub 2009 Jan 30.

DOI:10.1093/gerona/gln033
PMID:19181712
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2655004/
Abstract

BACKGROUND

Poor muscle size and function (sarcopenia) have an important role in the age-associated disability process. However, no commonly accepted index of sarcopenia exists for use in epidemiological studies.

METHODS

A cohort of 998 community-dwelling African Americans 49-65 years' old at baseline was used to construct the short portable sarcopenia measure (SPSM). SPSM was conceptualized as a measure of sarcopenia that combines estimates of muscle quantity and function into a single scale, is based on component items that can be obtained easily in the field, represents muscle status at a single time point that can be used without sex-specific adjustments, and can be used to follow change in muscle status over time with each person as his or her own control. We used exploratory factor analysis (EFA) to identify a unidimensional scale based on timed chair rises, lean mass, and grip strength divided by height. We used these three items and their EFA factor weights to construct SPSM (mean 9.0, median 9, range 0 [worst] to 18 [best] at baseline). Construct validity of the new measure, over a period of 36 months was examined.

RESULTS

SPSM required 8.5 pounds of equipment and 12.4 minutes to complete. It showed good score distribution and convergent, discriminant, and predictive validity with measures of muscle function, body composition, physical performance, psychological factors, and functional limitation cross-sectionally and with muscle function and body composition longitudinally. Extensive sensitivity analyses confirmed SPSM's robustness.

CONCLUSIONS

SPSM is a brief, portable, and valid measure of sarcopenia for use in epidemiological research. Similar studies in other populations are needed.

摘要

背景

肌肉量减少和功能减退(肌肉减少症)在与年龄相关的残疾过程中起重要作用。然而,目前尚无用于流行病学研究的被广泛接受的肌肉减少症指标。

方法

以一个由998名基线时年龄在49 - 65岁的非裔美国社区居民组成的队列构建简易便携式肌肉减少症测量方法(SPSM)。SPSM被概念化为一种肌肉减少症测量方法,它将肌肉量和功能的评估整合到一个单一量表中,基于可在现场轻松获取的组成项目,代表单个时间点的肌肉状态,无需进行性别特异性调整即可使用,并且可用于追踪每个人随时间的肌肉状态变化,以自身作为对照。我们使用探索性因子分析(EFA)基于定时从椅子上起身、瘦体重以及握力除以身高来确定一个单维量表。我们使用这三个项目及其EFA因子权重来构建SPSM(基线时均值为9.0,中位数为9,范围为0[最差]至18[最佳])。对新测量方法在36个月期间的结构效度进行了检验。

结果

SPSM需要8.5磅设备,完成时间为12.4分钟。它显示出良好的分数分布,并且在横断面以及纵向与肌肉功能、身体成分、身体表现、心理因素和功能受限的测量指标具有收敛效度、判别效度和预测效度。广泛的敏感性分析证实了SPSM的稳健性。

结论

SPSM是一种用于流行病学研究的简易、便携式且有效的肌肉减少症测量方法。需要在其他人群中开展类似研究。

相似文献

1
Development and validation of a short portable sarcopenia measure in the African American health project.非裔美国人健康项目中一种简短便携式肌肉减少症测量方法的开发与验证
J Gerontol A Biol Sci Med Sci. 2009 Mar;64(3):388-94. doi: 10.1093/gerona/gln033. Epub 2009 Jan 30.
2
Adherence to a standardized protocol for measuring grip strength and appropriate cut-off values in adults over 65 years with sarcopenia: a systematic review protocol.65岁以上患有肌肉减少症的成年人握力测量的标准化方案及适当临界值:一项系统评价方案
JBI Database System Rev Implement Rep. 2015 Oct;13(10):50-9. doi: 10.11124/jbisrir-2015-2256.
3
Prevalence and definition of sarcopenia in community dwelling older people. Data from the Berlin aging study II (BASE-II).社区居住老年人肌少症的患病率及定义。来自柏林衰老研究II(BASE-II)的数据。
Z Gerontol Geriatr. 2016 Feb;49(2):94-9. doi: 10.1007/s00391-015-0886-z. Epub 2015 Apr 16.
4
Physical function-derived cut-points for the diagnosis of sarcopenia and dynapenia from the Canadian longitudinal study on aging.基于身体功能的加拿大老龄化纵向研究中肌少症和无力症诊断切点
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):985-999. doi: 10.1002/jcsm.12462. Epub 2019 Jul 15.
5
Predicting fat-free mass index and sarcopenia: a pilot study in community-dwelling older adults.预测去脂体重指数和肌肉减少症:一项针对社区居住老年人的初步研究。
Age (Dordr). 2013 Dec;35(6):2423-34. doi: 10.1007/s11357-012-9505-8. Epub 2013 Jan 16.
6
Global variation in grip strength: a systematic review and meta-analysis of normative data.握力的全球差异:规范性数据的系统评价与荟萃分析
Age Ageing. 2016 Mar;45(2):209-16. doi: 10.1093/ageing/afv192. Epub 2016 Jan 19.
7
Patterns and Correlates of Grip Strength in Older Americans.美国老年人握力的模式及相关因素
Curr Aging Sci. 2018;11(1):63-70. doi: 10.2174/1874609810666171116164000.
8
Bioimpedance analysis and physical functioning as mortality indicators among older sarcopenic people.生物阻抗分析和身体机能作为老年肌少症人群的死亡指标。
Exp Gerontol. 2019 Jul 15;122:42-46. doi: 10.1016/j.exger.2019.04.012. Epub 2019 Apr 24.
9
Sarcopenia Definition & Outcomes Consortium Defined Low Grip Strength in Two Cross-Sectional, Population-Based Cohorts.肌肉减少症定义与结局联盟在两个基于人群的横断面队列中定义了低握力。
J Am Geriatr Soc. 2020 Jul;68(7):1438-1444. doi: 10.1111/jgs.16419. Epub 2020 Jul 7.
10
Predicting sarcopenia from functional measures among community-dwelling older adults.通过功能指标预测社区居住老年人的肌肉减少症
Age (Dordr). 2016 Feb;38(1):22. doi: 10.1007/s11357-016-9887-0. Epub 2016 Feb 4.

引用本文的文献

1
The Healthy Brain Initiative (HBI): A prospective cohort study protocol.健康大脑倡议(HBI):一项前瞻性队列研究方案。
PLoS One. 2023 Oct 27;18(10):e0293634. doi: 10.1371/journal.pone.0293634. eCollection 2023.
2
Screening Tools for Sarcopenia.肌少症筛查工具。
In Vivo. 2021 Nov-Dec;35(6):3001-3009. doi: 10.21873/invivo.12595.
3
The Quick Physical Activity Rating (QPAR) scale: A brief assessment of physical activity in older adults with and without cognitive impairment.快速体力活动评估(QPAR)量表:对认知障碍和非认知障碍老年人体力活动的简要评估。
PLoS One. 2020 Oct 30;15(10):e0241641. doi: 10.1371/journal.pone.0241641. eCollection 2020.
4
What older adults do with the results of dementia screening programs.老年人如何对待痴呆筛查项目的结果。
PLoS One. 2020 Jul 1;15(7):e0235534. doi: 10.1371/journal.pone.0235534. eCollection 2020.
5
Editorial: Screening for Sarcopenia.社论:肌肉减少症的筛查
J Nutr Health Aging. 2019;23(9):768-770. doi: 10.1007/s12603-019-1259-x.
6
Sarcopenic obesity and cognitive performance.肌少症性肥胖与认知表现。
Clin Interv Aging. 2018 Jun 6;13:1111-1119. doi: 10.2147/CIA.S164113. eCollection 2018.
7
Targeting Functional Decline in Alzheimer Disease: A Randomized Trial.针对阿尔茨海默病功能衰退的一项随机试验。
Ann Intern Med. 2017 Feb 7;166(3):164-171. doi: 10.7326/M16-0830. Epub 2016 Nov 22.
8
SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes.SARC - F:一种用于预测有肌肉减少症风险且功能预后较差人群的症状评分。
J Cachexia Sarcopenia Muscle. 2016 Mar;7(1):28-36. doi: 10.1002/jcsm.12048. Epub 2015 Jul 7.
9
Correlation Between Caregiver Reports of Physical Function and Performance-based Measures in a Cohort of Older Adults With Alzheimer Disease.阿尔茨海默病老年患者队列中照顾者报告的身体功能与基于表现的测量方法之间的相关性
Alzheimer Dis Assoc Disord. 2016 Apr-Jun;30(2):169-74. doi: 10.1097/WAD.0000000000000101.
10
Sarcopenia and impairment in cognitive and physical performance.肌肉减少症以及认知和身体机能受损。
Clin Interv Aging. 2015 Mar 30;10:663-71. doi: 10.2147/CIA.S76275. eCollection 2015.

本文引用的文献

1
Adverse outcomes and correlates of change in the Short Physical Performance Battery over 36 months in the African American health project.非裔美国人健康项目中36个月内简短体能测试电池组变化的不良后果及相关因素
J Gerontol A Biol Sci Med Sci. 2008 May;63(5):487-94. doi: 10.1093/gerona/63.5.487.
2
Is stair climb power a clinically relevant measure of leg power impairments in at-risk older adults?爬楼梯能力是否是评估高危老年人腿部力量受损的临床相关指标?
Arch Phys Med Rehabil. 2007 May;88(5):604-9. doi: 10.1016/j.apmr.2007.02.004.
3
Developmental origins of midlife grip strength: findings from a birth cohort study.中年握力的发育起源:一项出生队列研究的结果
J Gerontol A Biol Sci Med Sci. 2006 Jul;61(7):702-6. doi: 10.1093/gerona/61.7.702.
4
Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort.在健康、衰老和身体成分研究队列中,力量而非肌肉量与死亡率相关。
J Gerontol A Biol Sci Med Sci. 2006 Jan;61(1):72-7. doi: 10.1093/gerona/61.1.72.
5
Age trajectories of grip strength: cross-sectional and longitudinal data among 8,342 Danes aged 46 to 102.握力的年龄轨迹:8342名年龄在46至102岁之间的丹麦人的横断面和纵向数据。
Ann Epidemiol. 2006 Jul;16(7):554-62. doi: 10.1016/j.annepidem.2005.10.006. Epub 2006 Jan 10.
6
Inner city, middle-aged African Americans have excess frank and subclinical disability.美国市中心的中年非裔美国人存在过多明显的和亚临床的残疾情况。
J Gerontol A Biol Sci Med Sci. 2005 Feb;60(2):207-12. doi: 10.1093/gerona/60.2.207.
7
Reproducibility of physical performance and physiologic assessments.身体机能和生理评估的可重复性。
J Aging Health. 2005 Apr;17(2):111-24. doi: 10.1177/0898264304272784.
8
Carotenoid and vitamin E status are associated with indicators of sarcopenia among older women living in the community.在社区居住的老年女性中,类胡萝卜素和维生素E水平与肌肉减少症指标相关。
Aging Clin Exp Res. 2003 Dec;15(6):482-7. doi: 10.1007/BF03327377.
9
Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women.与老年男性和女性身体残疾风险升高相关的骨骼肌切点
Am J Epidemiol. 2004 Feb 15;159(4):413-21. doi: 10.1093/aje/kwh058.
10
Exercise, aging, and muscle protein metabolism.运动、衰老与肌肉蛋白质代谢。
J Gerontol A Biol Sci Med Sci. 2003 Oct;58(10):M918-22. doi: 10.1093/gerona/58.10.m918.